RU2319508C2 - Диспергируемый препарат противовоспалительного агента - Google Patents
Диспергируемый препарат противовоспалительного агента Download PDFInfo
- Publication number
- RU2319508C2 RU2319508C2 RU2006101628/14A RU2006101628A RU2319508C2 RU 2319508 C2 RU2319508 C2 RU 2319508C2 RU 2006101628/14 A RU2006101628/14 A RU 2006101628/14A RU 2006101628 A RU2006101628 A RU 2006101628A RU 2319508 C2 RU2319508 C2 RU 2319508C2
- Authority
- RU
- Russia
- Prior art keywords
- acid
- composition
- oil
- agent
- ear
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49212103P | 2003-07-31 | 2003-07-31 | |
| US60/492,121 | 2003-07-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2006101628A RU2006101628A (ru) | 2006-08-27 |
| RU2319508C2 true RU2319508C2 (ru) | 2008-03-20 |
Family
ID=34103027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006101628/14A RU2319508C2 (ru) | 2003-07-31 | 2004-07-19 | Диспергируемый препарат противовоспалительного агента |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1651210A1 (es) |
| JP (1) | JP2007500691A (es) |
| KR (1) | KR100780983B1 (es) |
| CN (1) | CN1829510A (es) |
| AU (1) | AU2004258745A1 (es) |
| BR (1) | BRPI0412581A (es) |
| CA (1) | CA2533101A1 (es) |
| CO (1) | CO5650245A2 (es) |
| IL (1) | IL172735A0 (es) |
| MX (1) | MXPA06001288A (es) |
| NO (1) | NO20060982L (es) |
| RU (1) | RU2319508C2 (es) |
| WO (1) | WO2005009436A1 (es) |
| ZA (1) | ZA200600096B (es) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2486905C1 (ru) * | 2012-05-28 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") | Средство для лечения мастита у животных |
| RU2549465C2 (ru) * | 2010-03-01 | 2015-04-27 | Лабораториос Салват, С.А. | Водные прозрачные растворы флуоцинолона ацетонида для лечения ушного воспаления |
| WO2017010856A1 (en) * | 2015-07-14 | 2017-01-19 | Rīgas Stradiņa Universitāte | Composition for treatment of subclinical mastitis of cows |
| RU2657828C2 (ru) * | 2015-08-27 | 2018-06-15 | Мин По СИМ | Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения |
| RU2675241C2 (ru) * | 2013-01-14 | 2018-12-18 | ИнФерст Хэлткэр Лимитед | Композиции твердых растворов и их применение при хроническом воспалении |
| RU2680801C2 (ru) * | 2013-02-04 | 2019-02-27 | ИнФерст Хэлткэр Лимитед | Композиции и способы для лечения хронического воспаления и воспалительных заболеваний |
| US10561684B2 (en) | 2015-08-27 | 2020-02-18 | Min Bo SHIM | Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same |
| RU2749857C1 (ru) * | 2019-12-23 | 2021-06-17 | Псарева Нелли Александровна | Способ борьбы со средним и наружным отитом |
| RU2751697C1 (ru) * | 2020-09-09 | 2021-07-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Донской государственный аграрный университет" | Средство для лечения отитов наружного слухового прохода у собак |
| RU2779111C2 (ru) * | 2017-02-28 | 2022-08-31 | Акусия Терапьютикс Гмбх | Новые соединения, используемые в качестве открывателей калиевых каналов |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20081406A1 (es) * | 2006-12-20 | 2008-10-17 | Schering Plough Ltd | Composiciones farmaceuticas de flunixina |
| GB0711776D0 (en) * | 2007-06-18 | 2007-07-25 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
| UA111147C2 (uk) * | 2009-11-11 | 2016-04-11 | Байєр Б.В. | Способи та композиції для лікування або профілактики зовнішнього отиту |
| GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
| US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| CN102784161A (zh) * | 2012-08-01 | 2012-11-21 | 张吉川 | 一种治疗急慢性中耳炎的特效滴耳液 |
| CN108135967B (zh) | 2015-08-05 | 2022-06-28 | 儿童医学中心公司 | 用于药物递送的具有渗透增强剂的组合物 |
| US20210115003A1 (en) * | 2018-03-29 | 2021-04-22 | Yale University | Novel fully synthetic and semisynthetic pleuromutilin derivatives as new antibiotics and their preparation |
| EP3829540A1 (en) * | 2018-08-01 | 2021-06-09 | Novilla Pharmaceuticals, Inc. | Eutectic solvents comprising pharmaceutical agents, and methods of making and use thereof |
| KR102461699B1 (ko) * | 2021-05-21 | 2022-11-03 | 현대약품 주식회사 | 벤지다민염산염을 포함하는 안정성이 개선된 가글액 |
| KR20230084419A (ko) * | 2021-12-03 | 2023-06-13 | (주)인비보텍 | 난청 또는 이명의 예방 또는 치료용 조성물 |
| KR20230084418A (ko) * | 2021-12-03 | 2023-06-13 | (주)인비보텍 | 난청 또는 이명의 예방 또는 치료용 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| EP0786986B1 (en) * | 1994-10-26 | 2002-03-20 | Novartis AG | Use of an unsaturated fatty alcohol |
| MX9701731A (es) * | 1995-06-06 | 1997-10-31 | Bayer Ag | Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido. |
| DZ2479A1 (fr) * | 1997-05-05 | 2003-02-01 | Pfizer | Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. |
| US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| IL152792A0 (en) * | 2000-06-08 | 2003-06-24 | Univ Texas | Heterocycle derivatives and methods of use |
| BR0111718A (pt) * | 2000-06-16 | 2003-09-09 | Hercules Inc | Peptìdeos quimicamente modificados, composições e métodos de produção e uso |
| BR0112878A (pt) * | 2000-09-12 | 2003-07-01 | Upjohn Co | Composição farmacêutica tendo atividade especìfica em água |
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
-
2004
- 2004-07-19 MX MXPA06001288A patent/MXPA06001288A/es not_active Application Discontinuation
- 2004-07-19 AU AU2004258745A patent/AU2004258745A1/en not_active Abandoned
- 2004-07-19 JP JP2006521702A patent/JP2007500691A/ja not_active Withdrawn
- 2004-07-19 CA CA002533101A patent/CA2533101A1/en not_active Abandoned
- 2004-07-19 BR BRPI0412581-9A patent/BRPI0412581A/pt not_active IP Right Cessation
- 2004-07-19 CN CNA200480022099XA patent/CN1829510A/zh active Pending
- 2004-07-19 EP EP04744112A patent/EP1651210A1/en not_active Withdrawn
- 2004-07-19 RU RU2006101628/14A patent/RU2319508C2/ru not_active IP Right Cessation
- 2004-07-19 KR KR1020067002034A patent/KR100780983B1/ko not_active IP Right Cessation
- 2004-07-19 WO PCT/IB2004/002461 patent/WO2005009436A1/en active Application Filing
-
2005
- 2005-12-21 IL IL172735A patent/IL172735A0/en unknown
- 2005-12-29 CO CO05130971A patent/CO5650245A2/es not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600096A patent/ZA200600096B/en unknown
- 2006-02-28 NO NO20060982A patent/NO20060982L/no not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| OWENS W.E. et al. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy // Journal of Dairy Science, vol.73, №12, 1990, p.3449-3456. * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2549465C2 (ru) * | 2010-03-01 | 2015-04-27 | Лабораториос Салват, С.А. | Водные прозрачные растворы флуоцинолона ацетонида для лечения ушного воспаления |
| RU2486905C1 (ru) * | 2012-05-28 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") | Средство для лечения мастита у животных |
| RU2675241C2 (ru) * | 2013-01-14 | 2018-12-18 | ИнФерст Хэлткэр Лимитед | Композиции твердых растворов и их применение при хроническом воспалении |
| RU2680801C2 (ru) * | 2013-02-04 | 2019-02-27 | ИнФерст Хэлткэр Лимитед | Композиции и способы для лечения хронического воспаления и воспалительных заболеваний |
| WO2017010856A1 (en) * | 2015-07-14 | 2017-01-19 | Rīgas Stradiņa Universitāte | Composition for treatment of subclinical mastitis of cows |
| RU2657828C2 (ru) * | 2015-08-27 | 2018-06-15 | Мин По СИМ | Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения |
| US10561684B2 (en) | 2015-08-27 | 2020-02-18 | Min Bo SHIM | Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same |
| RU2779111C2 (ru) * | 2017-02-28 | 2022-08-31 | Акусия Терапьютикс Гмбх | Новые соединения, используемые в качестве открывателей калиевых каналов |
| RU2749857C1 (ru) * | 2019-12-23 | 2021-06-17 | Псарева Нелли Александровна | Способ борьбы со средним и наружным отитом |
| RU2751697C1 (ru) * | 2020-09-09 | 2021-07-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Донской государственный аграрный университет" | Средство для лечения отитов наружного слухового прохода у собак |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005009436A1 (en) | 2005-02-03 |
| JP2007500691A (ja) | 2007-01-18 |
| AU2004258745A1 (en) | 2005-02-03 |
| BRPI0412581A (pt) | 2006-09-19 |
| EP1651210A1 (en) | 2006-05-03 |
| KR100780983B1 (ko) | 2007-11-30 |
| WO2005009436A8 (en) | 2005-05-06 |
| ZA200600096B (en) | 2007-02-28 |
| RU2006101628A (ru) | 2006-08-27 |
| KR20060031873A (ko) | 2006-04-13 |
| CN1829510A (zh) | 2006-09-06 |
| NO20060982L (no) | 2006-05-02 |
| IL172735A0 (en) | 2006-04-10 |
| MXPA06001288A (es) | 2006-04-11 |
| CA2533101A1 (en) | 2005-02-03 |
| CO5650245A2 (es) | 2006-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2319508C2 (ru) | Диспергируемый препарат противовоспалительного агента | |
| RU2325189C2 (ru) | Способ и фармацевтическая композиция для доставки противовоспалительного средства | |
| KR100765614B1 (ko) | 유방염 및 이질환 치료용 분산성 제약 조성물 | |
| US20080153894A1 (en) | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis | |
| US20050009931A1 (en) | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders | |
| US20050004098A1 (en) | Dispersible formulation of an anti-inflammatory agent | |
| US20040033938A1 (en) | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis | |
| ZA200600850B (en) | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090720 |